Expanding Diagnostics Portfolio ACON Laboratories has a strong focus on rapid diagnostic tests, including COVID-19 antigen tests and other point-of-care products, which presents opportunities to promote their expanding portfolio to healthcare providers, pharmacies, and retail outlets seeking reliable, cost-effective testing solutions.

International Market Presence With a well-established presence in over 130 countries and recent collaborations such as with AusDiagnostics Australia, there is a clear opportunity to tailor sales strategies for regional markets, leveraging existing partnerships and emphasizing product availability and regulatory approvals in targeted regions.

Innovation in Rapid Testing Recent product launches like the On Call Express Voice and mobile diagnostic systems indicate a technology-driven approach, providing sales channels with prospects to introduce integrated, user-friendly testing solutions that meet the needs of healthcare professionals and consumers.

Growth in COVID-19 Testing Since launching multiple COVID-19 testing products and engaging in international distribution efforts, ACON is positioned for continued growth in infectious disease diagnostics, offering opportunities to expand into new markets or develop complementary testing methods and devices.

Market Competitiveness Operating within a competitive space alongside companies like Dexcom and Insulet, ACON’s focus on affordable, high-quality diagnostics creates sales potential in segments where cost-efficiency and regulatory compliance are key decision factors for healthcare buyers and distributors.